Page last updated: 2024-10-31

metoprolol and Secondary Hyperparathyroidism

metoprolol has been researched along with Secondary Hyperparathyroidism in 2 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fournier, A1
Coevoet, B1
de Fremont, JF1
Gueris, J1
Caillens, G1
Desplan, C1
Calmette, C1
Moukhtar, MS1
Takeda, K1
Kusano, E1
Asano, Y1
Hosoda, S1

Other Studies

2 other studies available for metoprolol and Secondary Hyperparathyroidism

ArticleYear
Propranolol therapy for secondary hyperparathyroidism in uraemia.
    Lancet (London, England), 1978, Jul-01, Volume: 2, Issue:8079

    Topics: Calcitonin; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Metoprolol; Parathyro

1978
Beta-antagonist and secondary hyperparathyroidism in chronic renal failure.
    Nihon Jinzo Gakkai shi, 1985, Volume: 27, Issue:9

    Topics: Adult; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Metoprolol; Mi

1985